Resources

1 Resources for

carol flake chapman

Subscribe to this listing via:
RSS
Email

BNET Resources

Valeant: It Turns Out that Wrinkles Are Worth Quite a Lot: Carol Flake Chapman submits: I wrote about Valeant Pharmaceuticals VRX back on June 16, when the stock was trading at a little over $22. The company came to my notice because of Efudex, its treatment for actinic keratosis and basal cell carcinoma. Not only does the treatment work to remedy...; Tags: Healthcare, Carol Flake Chapman, Valeant Pharmaceuticals International; External links 2009-11-02

<< Previous
page 1 of 1
Next >>

Click Here

Your Work The 7 Interview Questions You Must Ask

The 7 Interview Questions You Must Ask

Forget 'What are your strengths and weaknesses?' If you want to get the real dope on prospective employees, ask job candidates these seven questions.
Your Industry Walmart Can't Kill Every Retail Niche; Jo-Ann Shows Why

Walmart Can't Kill Every Retail Niche; Jo-Ann Shows Why

Jo-Ann Stores is posting impressive sales and earnings numbers and is an example of a retail sector on which Walmart doesn't have a steel grip.
Your Money 8 Phony 'Bargains' and Better Alternatives

8 Phony 'Bargains' and Better Alternatives

In this economy, enticing offers abound. But a lot of so-called bargains may turn out to be raw deals.

Presented by American Express